{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:59:41Z","timestamp":1790755181558,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12974-014-0203-6","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T18:38:02Z","timestamp":1418323082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia"],"prefix":"10.1186","volume":"11","author":[{"given":"Bettina Hjelm","family":"Clausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Degn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellie Anne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Couch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ormh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Louise Bergholdt","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Birgit","family":"Gredal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian IL","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Szymkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine H","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Finsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Clive","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Lykke","family":"Lambertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"203_CR1","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","volume":"32","author":"KL Lambertsen","year":"2012","unstructured":"Lambertsen KL, Biber K, Finsen B: Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012, 32: 1677-1698. 10.1038\/jcbfm.2012.88.","journal-title":"J Cereb Blood Flow Metab"},{"key":"203_CR2","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1002\/eji.200635921","volume":"36","author":"L Alexopoulou","year":"2006","unstructured":"Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL, Kollias G: Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur J Immunol. 2006, 36: 2768-2780. 10.1002\/eji.200635921.","journal-title":"Eur J Immunol"},{"key":"203_CR3","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/brain\/awr199","volume":"134","author":"R Brambilla","year":"2011","unstructured":"Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, Bethea JR: Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain. 2011, 134: 2736-2754. 10.1093\/brain\/awr199.","journal-title":"Brain"},{"key":"203_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1074-7613(01)00215-1","volume":"15","author":"SR Ruuls","year":"2001","unstructured":"Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ, Korner H, Scheerens H, Hessel EM, Cyster JG, McEvoy LM, Sedgwick JD: Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity. 2001, 15: 533-543. 10.1016\/S1074-7613(01)00215-1.","journal-title":"Immunity"},{"key":"203_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006, 367: 29-35. 10.1016\/S0140-6736(05)67763-X.","journal-title":"Lancet"},{"key":"203_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","volume":"5","author":"PC Taylor","year":"2009","unstructured":"Taylor PC, Feldmann M: Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5: 578-582. 10.1038\/nrrheum.2009.181.","journal-title":"Nat Rev Rheumatol"},{"key":"203_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/11588400-000000000-00000","volume":"25","author":"E Tobinick","year":"2011","unstructured":"Tobinick E: Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs. 2011, 25: 145-155. 10.2165\/11588400-000000000-00000.","journal-title":"CNS Drugs"},{"key":"203_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s40263-012-0013-2","volume":"26","author":"E Tobinick","year":"2012","unstructured":"Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V: Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2012, 26: 1051-1070. 10.1007\/s40263-012-0013-2.","journal-title":"CNS Drugs"},{"key":"203_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/09546630410017275","volume":"15","author":"N Scheinfeld","year":"2004","unstructured":"Scheinfeld N: A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat. 2004, 15: 280-294. 10.1080\/09546630410017275.","journal-title":"J Dermatolog Treat"},{"key":"203_CR10","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1126\/science.1081297","volume":"301","author":"PM Steed","year":"2003","unstructured":"Steed PM, Tansey MG, Zalevsky J, Zhukovsky EA, Desjarlais JR, Szymkowski DE, Abbott C, Carmichael D, Chan C, Cherry L, Cheung P, Chirino AJ, Chung HH, Doberstein SK, Eivazi A, Filikov AV, Gao SX, Hubert RS, Hwang M, Hyun L, Kashi S, Kim A, Kim E, Kung J, Martinez SP, Muchhal US, Nguyen D-HT, O\u2019Brien C, O\u2019Keefe D, Singer K, Vafa O, Vielmetter J, Yoder SC, Dahiyat BI: Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Science. 2003, 301: 1895-1898. 10.1126\/science.1081297.","journal-title":"Science"},{"key":"203_CR11","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","volume":"26","author":"MK McCoy","year":"2006","unstructured":"McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG: Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease. J Neurosci. 2006, 26: 9365-9375. 10.1523\/JNEUROSCI.1504-06.2006.","journal-title":"J Neurosci"},{"key":"203_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12974-014-0159-6","volume":"11","author":"HG Novrup","year":"2014","unstructured":"Novrup HG, Bracchi-Ricard V, Ellman DG, Ricard J, Jain A, Runko E, Lyck L, Yli-Karjanmaa M, Szymkowski DE, Pearse DD, Lambertsen KL, Bethea JR: Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice. J Neuroinflammation. 2014, 11: 159-10.1186\/s12974-014-0159-6.","journal-title":"J Neuroinflammation"},{"key":"203_CR13","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","volume":"179","author":"J Zalevsky","year":"2007","unstructured":"Zalevsky J, Secher T, Ezhevsky SA, Janot L, Steed PM, O\u2019Brien C, Eivazi A, Kung J, Nguyen DH, Doberstein SK, Erard F, Ryffel B, Szymkowski DE: Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol. 2007, 179: 1872-1883. 10.4049\/jimmunol.179.3.1872.","journal-title":"J Immunol"},{"key":"203_CR14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1086\/597204","volume":"199","author":"ML Olleros","year":"2009","unstructured":"Olleros ML, Vesin D, Lambou AF, Janssens JP, Ryffel B, Rose S, Fremond C, Quesniaux VF, Szymkowski DE, Garcia I: Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guerin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. J Infect Dis. 2009, 199: 1053-1063. 10.1086\/597204.","journal-title":"J Infect Dis"},{"key":"203_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00004647-200001000-00009","volume":"20","author":"R Gregersen","year":"2000","unstructured":"Gregersen R, Lambertsen K, Finsen B: Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2000, 20: 53-65. 10.1097\/00004647-200001000-00009.","journal-title":"J Cereb Blood Flow Metab"},{"key":"203_CR16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1523\/JNEUROSCI.5505-08.2009","volume":"29","author":"KL Lambertsen","year":"2009","unstructured":"Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, F\u00e6rgeman NJ, Meldgaard M, Deierborg T, Finsen B: Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci. 2009, 29: 1319-1330. 10.1523\/JNEUROSCI.5505-08.2009.","journal-title":"J Neurosci"},{"key":"203_CR17","doi-asserted-by":"publisher","first-page":"e47744","DOI":"10.1371\/journal.pone.0047744","volume":"7","author":"KL Lambertsen","year":"2012","unstructured":"Lambertsen KL, Gramsbergen JB, Sivasaravanaparan M, Ditzel N, Sevelsted-Moller LM, Olivan-Viguera A, Rabjerg M, Wulff H, Kohler R: Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels. PLoS One. 2012, 7: e47744-10.1371\/journal.pone.0047744.","journal-title":"PLoS One"},{"key":"203_CR18","doi-asserted-by":"publisher","first-page":"e60691","DOI":"10.1371\/journal.pone.0060691","volume":"8","author":"GH Petit","year":"2013","unstructured":"Petit GH, Berkovich E, Hickery M, Kallunki P, Fog K, Fitzer-Attas C, Brundin P: Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson\u2019s disease. PLoS One. 2013, 8: e60691-10.1371\/journal.pone.0060691.","journal-title":"PLoS One"},{"key":"203_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1742-2094-5-46","volume":"5","author":"BH Clausen","year":"2008","unstructured":"Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B: Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 2008, 5: 46-10.1186\/1742-2094-5-46.","journal-title":"J Neuroinflammation"},{"key":"203_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbi.2012.12.017","volume":"29","author":"Y Couch","year":"2013","unstructured":"Couch Y, Anthony DC, Dolgov O, Revischin A, Festoff B, Santos AI, Steinbusch HW, Strekalova T: Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun. 2013, 29: 136-146. 10.1016\/j.bbi.2012.12.017.","journal-title":"Brain Behav Immun"},{"key":"203_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.jcbfm.9600014","volume":"25","author":"KL Lambertsen","year":"2005","unstructured":"Lambertsen KL, Meldgaard M, Ladeby R, Finsen B: A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2005, 25: 119-135. 10.1038\/sj.jcbfm.9600014.","journal-title":"J Cereb Blood Flow Metab"},{"key":"203_CR22","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ajpath.2011.06.006","volume":"179","author":"H Hvilsted Nielsen","year":"2011","unstructured":"Hvilsted Nielsen H, Toft-Hansen H, Lambertsen KL, Owens T, Finsen B: Stimulation of adult oligodendrogenesis by myelin-specific T cells. Am J Pathol. 2011, 179: 2028-2041. 10.1016\/j.ajpath.2011.06.006.","journal-title":"Am J Pathol"},{"key":"203_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.nano.2011.04.003","volume":"7","author":"RA Dragovic","year":"2011","unstructured":"Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011, 7: 780-788. 10.1016\/j.nano.2011.04.003.","journal-title":"Nanomedicine"},{"key":"203_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/00004647-200207000-00004","volume":"22","author":"KL Lambertsen","year":"2002","unstructured":"Lambertsen KL, Gregersen R, Finsen B: Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab. 2002, 22: 785-797. 10.1097\/00004647-200207000-00004.","journal-title":"J Cereb Blood Flow Metab"},{"key":"203_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/jscd.2003.14","volume":"12","author":"FF Johansen","year":"2003","unstructured":"Johansen FF, Jorgensen HS, Reith J: Prolonged drug-induced hypothermia in experimental stroke. J Stroke Cerebrovasc Dis. 2003, 12: 97-102. 10.1053\/jscd.2003.14.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"203_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000026325","volume":"5","author":"N Yu","year":"1998","unstructured":"Yu N, Zhang X, Magistretti PJ, Bloom FE: IL-1-alpha and TNF-alpha differentially regulate CD4 and Mac-1 expression in mouse microglia. Neuroimmunomodulation. 1998, 5: 42-52. 10.1159\/000026325.","journal-title":"Neuroimmunomodulation"},{"key":"203_CR27","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.4049\/jimmunol.1000126","volume":"184","author":"BA Sayed","year":"2010","unstructured":"Sayed BA, Christy AL, Walker ME, Brown MA: Meningeal mast cells affect early T cell central nervous system infiltration and blood\u2013brain barrier integrity through TNF: a role for neutrophil recruitment?. J Immunol. 2010, 184: 6891-6900. 10.4049\/jimmunol.1000126.","journal-title":"J Immunol"},{"key":"203_CR28","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1111\/j.1471-4159.2007.04928.x","volume":"103","author":"SJ Campbell","year":"2007","unstructured":"Campbell SJ, Jiang Y, Davis AE, Farrands R, Holbrook J, Leppert D, Anthony DC: Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J Neurochem. 2007, 103: 2245-2255. 10.1111\/j.1471-4159.2007.04928.x.","journal-title":"J Neurochem"},{"key":"203_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.clim.2005.01.007","volume":"115","author":"C Shen","year":"2005","unstructured":"Shen C, Maerten P, Geboes K, Van Assche G, Rutgeerts P, Ceuppens JL: Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clin Immunol. 2005, 115: 250-259. 10.1016\/j.clim.2005.01.007.","journal-title":"Clin Immunol"},{"key":"203_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neulet.2013.02.051","volume":"542","author":"MD King","year":"2013","unstructured":"King MD, Alleyne CH, Dhandapani KM: TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice. Neurosci Lett. 2013, 542: 92-96. 10.1016\/j.neulet.2013.02.051.","journal-title":"Neurosci Lett"},{"key":"203_CR31","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/jcbfm.2012.97","volume":"32","author":"RK Sumbria","year":"2012","unstructured":"Sumbria RK, Boado RJ, Pardridge WM: Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab. 2012, 32: 1933-1938. 10.1038\/jcbfm.2012.97.","journal-title":"J Cereb Blood Flow Metab"},{"key":"203_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-140410","volume":"4","author":"CJ Barnum","year":"2014","unstructured":"Barnum CJ, Chen X, Chung J, Chang J, Williams M, Grigoryan N, Tesi RJ, Tansey MG: Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro(R)1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats. J Parkinson\u2019s Dis. 2014, 4: 349-360.","journal-title":"J Parkinson\u2019s Dis"},{"key":"203_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0301-0082(02)00128-4","volume":"68","author":"MA Petty","year":"2002","unstructured":"Petty MA, Lo EH: Junctional complexes of the blood\u2013brain barrier: permeability changes in neuroinflammation. Prog Neurobiol. 2002, 68: 311-323. 10.1016\/S0301-0082(02)00128-4.","journal-title":"Prog Neurobiol"},{"key":"203_CR34","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.23608","volume":"58","author":"MK Boettger","year":"2008","unstructured":"Boettger MK, Hensellek S, Richter F, Gajda M, Stockigt R, von Banchet GS, Brauer R, Schaible HG: Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum. 2008, 58: 2368-2378. 10.1002\/art.23608.","journal-title":"Arthritis Rheum"},{"key":"203_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/01.STR.30.1.134","volume":"30","author":"SG Soriano","year":"1999","unstructured":"Soriano SG, Coxon A, Wang YF, Frosch MP, Lipton SA, Hickey PR, Mayadas TN: Mice deficient in Mac-1 (CD11b\/CD18) are less susceptible to cerebral ischemia\/reperfusion injury. Stroke. 1999, 30: 134-139. 10.1161\/01.STR.30.1.134.","journal-title":"Stroke"},{"key":"203_CR36","doi-asserted-by":"publisher","first-page":"620837","DOI":"10.1155\/2013\/620837","volume":"2013","author":"CU Cheong","year":"2013","unstructured":"Cheong CU, Chang CP, Chao CM, Cheng BC, Yang CZ, Chio CC: Etanercept attenuates traumatic brain injury in rats by reducing brain TNF- alpha contents and by stimulating newly formed neurogenesis. Mediators Inflamm. 2013, 2013: 620837-10.1155\/2013\/620837.","journal-title":"Mediators Inflamm"},{"key":"203_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2202-14-33","volume":"14","author":"CC Chio","year":"2013","unstructured":"Chio CC, Chang CH, Wang CC, Cheong CU, Chao CM, Cheng BC, Yang CZ, Chang CP: Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-alpha. BMC Neurosci. 2013, 14: 33-10.1186\/1471-2202-14-33.","journal-title":"BMC Neurosci"},{"key":"203_CR38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1471-4159.2010.06969.x","volume":"115","author":"CC Chio","year":"2010","unstructured":"Chio CC, Lin JW, Chang MW, Wang CC, Kuo JR, Yang CZ, Chang CP: Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem. 2010, 115: 921-929. 10.1111\/j.1471-4159.2010.06969.x.","journal-title":"J Neurochem"},{"key":"203_CR39","first-page":"901420","volume":"2013","author":"K Li","year":"2013","unstructured":"Li K, Tan YH, Light AR, Fu KY: Different peripheral tissue injury induces differential phenotypic changes of spinal activated microglia. Clin Dev Immunol. 2013, 2013: 901420.","journal-title":"Clin Dev Immunol"},{"key":"203_CR40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.23627","volume":"72","author":"C Verderio","year":"2012","unstructured":"Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, Maiorino C, Servida F, Vercelli A, Rocca M, Dalla Libera D, Martinelli V, Comi G, Martino G, Matteoli M, Furlan R: Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol. 2012, 72: 610-624. 10.1002\/ana.23627.","journal-title":"Ann Neurol"},{"key":"203_CR41","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/j.1538-7836.2006.01911.x","volume":"4","author":"J Simak","year":"2006","unstructured":"Simak J, Gelderman MP, Yu H, Wright V, Baird AE: Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost. 2006, 4: 1296-1302. 10.1111\/j.1538-7836.2006.01911.x.","journal-title":"J Thromb Haemost"},{"key":"203_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W: Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013, 200: 373-383. 10.1083\/jcb.201211138.","journal-title":"J Cell Biol"},{"key":"203_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/157489007779606121","volume":"2","author":"LC Azevedo","year":"2007","unstructured":"Azevedo LC, Pedro MA, Laurindo FR: Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2007, 2: 41-51. 10.2174\/157489007779606121.","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"203_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","volume":"19","author":"LE Bautista","year":"2005","unstructured":"Bautista LE, Vera LM, Arenas IA, Gamarra G: Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005, 19: 149-154. 10.1038\/sj.jhh.1001785.","journal-title":"J Hum Hypertens"},{"key":"203_CR45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/HYPERTENSIONAHA.110.157685","volume":"56","author":"M Venegas-Pont","year":"2010","unstructured":"Venegas-Pont M, Manigrasso MB, Grifoni SC, LaMarca BB, Maric C, Racusen LC, Glover PH, Jones AV, Drummond HA, Ryan MJ: Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension. 2010, 56: 643-649. 10.1161\/HYPERTENSIONAHA.110.157685.","journal-title":"Hypertension"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-014-0203-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-014-0203-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-014-0203-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-014-0203-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:46:43Z","timestamp":1630565203000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-014-0203-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":45,"aliases":["10.1186\/preaccept-2982253041347736"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1186\/s12974-014-0203-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"4 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"203"}}